trending Market Intelligence /marketintelligence/en/news-insights/trending/9zdnvtzgaqvtsi66j052qa2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Biocept completes rights offering to raise $10.4M

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity


Biocept completes rights offering to raise $10.4M

Biocept Inc. completed a rights offering to raise about $10.4 million in net proceeds.

The San Diego-based company sold 11,587 units consisting of 11,587 shares of series A preferred stock and 2,549,140 warrants, with each warrant exercisable for one common stock at $4.53 per share.

Maxim Group LLC and Dawson James Securities Inc. acted as co-dealer-managers for the offering.

Biocept is a molecular diagnostics company that provides assays for lung, breast, gastric, colorectal, prostate and skin cancers.